AEBSF Hydrochloride 100 mg | ≥98% LKT Laboratories, Inc. Serine protease substrate/inhibitor. More Information Supplier Page × AEBSF Hydrochloride
AEBSF Hydrochloride 25 mg | ≥98% LKT Laboratories, Inc. Serine protease substrate/inhibitor. More Information Supplier Page × AEBSF Hydrochloride
ALLN 25 mg | ≥98% LKT Laboratories, Inc. Calpain I/II inhibitor. More Information Supplier Page × ALLN
ALLN 5 mg | ≥98% LKT Laboratories, Inc. Calpain I/II inhibitor. More Information Supplier Page × ALLN
MG-132 25 mg | ≥98% LKT Laboratories, Inc. Proteasome inhibitor. More Information Supplier Page × MG-132
MG-132 5 mg | ≥98% LKT Laboratories, Inc. Proteasome inhibitor. More Information Supplier Page × MG-132
GSK-1838705A 5 mg | ≥98% LKT Laboratories, Inc. ALK and IGF-1R inhibitor. More Information Supplier Page × GSK-1838705A
GSK-1838705A 1 mg | ≥98% LKT Laboratories, Inc. ALK and IGF-1R inhibitor. More Information Supplier Page × GSK-1838705A
GSK-1904529A 25 mg | ≥98% LKT Laboratories, Inc. InsR and IGF-1R inhibitor. More Information Supplier Page × GSK-1904529A
GSK-1904529A 5 mg | ≥98% LKT Laboratories, Inc. InsR and IGF-1R inhibitor. More Information Supplier Page × GSK-1904529A
